TELA Bio Inc. (TELA)
1.23
-0.17 (-12.14%)
At close: Mar 25, 2025, 3:59 PM
-12.14% (1D)
| Bid | 1.23 |
| Market Cap | 48.45M |
| Revenue (ttm) | 109.46M |
| Net Income (ttm) | -66.21M |
| EPS (ttm) | -1.33 |
| PE Ratio (ttm) | -0.92 |
| Forward PE | -4.21 |
| Analyst | Buy |
| Ask | 1.24 |
| Volume | 1,321,795 |
| Avg. Volume (20D) | 205,738 |
| Open | 1.38 |
| Previous Close | 1.40 |
| Day's Range | 1.22 - 1.38 |
| 52-Week Range | 1.20 - 6.50 |
| Beta | 1.10 |
About TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and r...
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 8, 2019
Employees 227
Stock Exchange NASDAQ
Ticker Symbol TELA
Website https://www.telabio.com
Analyst Forecast
According to 5 analyst ratings, the average rating for TELA stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 469.06% from the latest price.
Stock ForecastsEarnings Surprise
TELA Bio has released their quartely earnings
on Mar 20, 2025:
Next Earnings Release
TELA Bio Inc. is scheduled to release its earnings on May 8, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
-37.18%
TELA Bio shares are trading lower after the compan...
Unlock content with
Pro Subscription
6 days ago
-0.85%
TELA Bio shares are trading lower after the company reported Q4 financial results and missed its EPS and revenue estimates.
